"VFS": tohutohu mō te whakamahi. Analogs, arotake me contraindications "VFS"

"VFS" Papa ko te rōpū piha tuatahi o āpiha antiarrhythmic. He raau nehenehe o ārai takere konutai i roto i kiriuhi o cardiomyocytes. whakaoho tērā te reira i intraventricular me fakanounoui āriponga atrioventricular wā mahi me te whai hua whakangutungutu i roto i te atria, poraka peka paihere, AV-kōpuku me muka Purkinje. Tikanga tino kahore pānga i runga i te roanga o te QT-āputa, auau o contractions. I roto i te ngaro o faaiteraa tuatahi o te mahi iti cardiac, tarukino "VFS" (kei ako ā-taua mōhiohio) e kore pānga i runga i contractility myocardial. e kore e pā te reira i te kawe ia o te aronga kōpuku anterograde atrioventricular. Agent e kore pānga hypotensive kino. I roto i te mahi e kore e te reira tohua mana inotropic. A, no te fariiraa i te rongoā e kore e leva i roto i te automaticity pakohu kōpuku. He antispasmodic, whakarehu rohe, me te mahi anticholinergic āhua he kore tohu mahu'inga haumanu. He iti koronarorasshiryayuschee, āhuatanga whakarokiroki. Ko te pānga o te ā-waha tohu e wha tekau ranei e ono tekau meneti. tae te reira i mahi mōrahi i muri i 80 meneti. Ko te roanga o te mahi whakaora - na 8 haora.

Pharmacokinetics i roto i te wā whānui

Ko te bioavailability o āhua 40%. metabolized te raau i roto i te ate, me he taea ki te kuhu ki te BBB. Excretion o te raau taero puta i roto i te mimi. A, no te nui haere maumaui o wā mahi tākihi o te excretion e 2-3 wā.

He aha te tikanga o "VFS" tohu mo te whakamahi?

tohua te tarukino te mo te ventricular me extrasystoles supraventricular, paroxysmal tachycardia me te momo (kahore pāpaka i roto i te ngakau o te āhua organic me syndrome WPW), kaka Atrial me paroxysms Atrial.

talena dosing

E taunaki ana Te faaineineraa "VFS" ā-ako he horopeta - 25 mg 1 wa ia 8 haora. I roto i te ngaro o faaite medicament hua whakaora tangohia nga 6 haora. I roto i ētahi wā whakaaetia ki te ara horopeta rua kotahi (50 mg). Te wā wā i roto i tenei take, ko te 6-8 haora.

Ko te ra e kore ake atu i te 300 mg te mōrahi e whakaaetia. Ko te roanga o te therapy me tikanga mo te ako iahiko te fariiraa i te mātanga i whakaritea. Medicine inu i muri i te kai. Patupatua e kuru kore te te taputapu tukua ranei.

Medicament "VFS": pānga taha

He pai te Kaupapa ki prescriptions tarukino o te tākuta nohotahi e tūroro o reanga katoa nui. Heoi, i reira te mea he pea o ngā pānga kōaro i runga i te pūtake o te tarukino therapy "VFS". ko te kupu kia pānga taha i rerekē nekehanga o te pakeke. Ka taea e te kaihoko whakapataritari raruraru i roto i nga mahi o te pūnaha io piringa, me te pokapū. I roto i ngā, i reira he whanoke, diplopia, ataxia. I roto i te mau hopearaa ino o te pānga o te raau taero i runga i nga tohunga pūnaha Cardiovascular mōhio maumaui kitea o te kawenga intraventricular me atrioventricular, te whanaketanga o te pakohu tachycardia (ki maimoatanga wā roa-). faaiteraa kino ngā pānga arrhythmogenic, te roa o QP-whānui, roha o te huringa QRS-matatini, me te tahi atu i roto i te tauira ECG. I runga i te pūtake o te tarukino therapy "VFS" (faaara ako ā-e pā ana ki reira) puta whero o te kiri, te mamae i roto i te upoko ranei te mana'o o te pouri. wheako ētahi tūroro i te tauhohenga pāwera (ponana ritenga kiri ranei). Kei te reira i ngā mōhiohio e pā ana ki te pānga kino o te rongoā "VFS" ā-ako. Reviews ngaio e pā ana ki te tikanga mateā, i roto i te whānui, pai. Heoi, homai te mafatukituki o etahi o nga mau faahopearaa ino o te raau taero kawea i roto i raro i te te tirotiro tata o te rata.
I roto i te kaupapa o pōauautanga me ino kia toro tonu te mātanga. I roto i tenei take, i te tākuta kia whiriwhiri hei utu te tikanga "VFS" raau taero rite.

A, no te kore e whakaritea ki te rongoā?

Contraindications ngā ru cardiogenic, poraka atrioventricular i roto i te toru me te rua o nga wā (i roto i te ngaro o te manawataki ngakau tāwhaiwhai o te taraiwa). E kore e whakaaetia te reira ki te inu rongoa mo takawhita i roto i te wā uaua (pēhanga systolic iti iho i te 90 mm / HG.), hypertrophy i te myocardium o te mānawanawa maui korerotia. raau taero rāhuitia i roto i te cardiosclerosis pou-infarction. E kore te te tarukino tūtohutia hoki te pā o matau nga waewae poraka manga paihere (ka ngā ki disorders i roto i te peka i te taha ki maui), ma'i ngakau kore mahi āhua me te kino. Contraindicated rongoā ki 18 tau (e tika ana ki te meka e kore te mea whakapumautia haumaru me te aonga o āpiha), te huahuka ātete. E kore e whakaaetia te reira ki te tango i te rongoā mo te iwi ki te syndrome o galactose waimaero resorption / kūhuka, hapūtanga, isomaltase takarepa / sucrose. Ehara i raau tūtohutia hoki hypersensitivity ki te wae. Ki te hiahia koe ki te noho i te therapy atawhai ki te manawanui, e hiahia ana koe ki te mutu hohipera.

A, no te hiahia koe i te whakatikatikanga horopeta?

I te tahi taime i reira he he hiahia ki te huri i taputapu "VFS" te fariiraa i ara iahiko. Tohutohu, kōrero i nga tohunga i roto i ngā mōhiohio e whakaiti te nui o te tarukino ranei whakanui i te wā i waenganui i taea te tūtohutia pota ki poraka atrioventricular i roto i te tohu tuatahi, i roto i disorders āriponga intraventricular, bradycardia. WHAKATŪPATO ū ki koki-katinga papahewa, disorders circulatory (piringa) natura taimaha hypertrophy i roto i te kopa repeure. iahiko te ako e hiahiatia ana i runga i te pūtake o te kawehiko pākia taui kawe ia i roto i muka Purkinje, pā o tetahi o nga waewae i roto i te poraka manga paihere. hiahiatia tūpato te ina antiritmicheskih te whiwhi i ētahi atu rongoā tukutahi ki te rongoa "VFS". Reviews o tohunga maha he tino maro, i runga i te take o ngā rerekētanga i roto i te inenga ki kahore pānga.

Mō ētahi atu pārongo,

I mua i te tīmata i te therapy faaore disorders o te wai me te kawehiko toenga i roto i te tukanga o te fariiraa i te rongoā, ko te tika ki te whakarite i te mana tamau, me te tupato ki runga reira. kia whakanui i paepae whakaongaonga cardiac i roto i tūroro e kua i te whakaeke ngakau (whakapeka), kore ngakau, i te pacemaker tāwhaiwhai ranei. I roto i te kaupapa o te whanoke, kite rua, tūtohutia pāhoahoa ki te whakaiti i te inenga. A, no te te tachycardia pakohu e whakaritea i runga i te pūtake o te roa fariiraa tarukino beta-blockers rite hiahiatia. E tūtohutia ēnei taka i roto i te pota iti. I runga i te pūtake o te maimoatanga me kia tupato ka mahi ngā mahi pea mōrearea e hiahia whakarongo me te kukū tere te tauhohenga ranei nui haere.

tuwhena rawa

Nā ki te meka e te raau taero e te whanui iti o te mahi whakaora, Ka taea e haurangi nui puta ngāwari nui. mōrea Rawa nui o poisoning ki runga ki te taenga o te tahi atu raau taero antiarrhythmic. I roto i te tuwhena rawa tohua PR- elongation me QT-wā, ake i amplitudes T-poipoi roha QRS-matatini. Ki whakatika te whakamārama o te haurangi asystole, bradycardia, heke contractility i te myocardium. Kei te kitea hoki te manawanui sinotrialnaya pā, whakaiti i te pēhanga korerotia, disorders pūnaha kūnatu. tahi haurangi e paroxysmal tachycardia Polymorphic ventricular, kite te peroo, whanoke, mamae i roto i te upoko. I roto i te kaupapa o te maimoatanga symptomatic tuwhena rawa whakaaturia te. Maimoatanga o te ventricular tachycardia kawea i roto i ki te whakamahi o te raau taero antiarrhythmic kāwai ahau A ko ahau C Roha QRS-matatini, to'o hypotension me bradycardia konutai hauwai pākawa waro.

Ngā pāhekoheko ki ētahi atu medicaments

A, no te riro tahi me whāpoapoa o microsomal ate whākōkī tarukino miramira "VFS" heke. faarahi tenei te mōrea o ngā pānga paitini. A, no te fariiraa i taero antiarrhythmic o te tahi atu akomanga nui haere tūponotanga o te whakawhanake mana arrhythmogenic. whakatairanga hoki i te taputapu te mahi o relaxants uaua depolarizing-kore.

I reira ko te tarukino whai hua ki te tikanga rite o te mahi?

Tikanga "Allaritmin" kei te taonga kaha taua rite te rongoā "VFS" - hydrobromide lappaconitine. E pā ana te medicament ki te ahau o te piha haapiiraa taero antiarrhythmic. "Allaritmin" he wātea i roto i te puka papa me rite te otinga mō te werohia ki te uaua i te rua ranei te rongoā. A, no te riro-waha, puta te pānga medicament i roto i pā ana ki te haora. I muri 4-5 haora, tae te tōtika mōrahi. Duration o pānga - 8 haora, neke atu rānei. Ko te kupu whakataki o te pānga kore o te tarukino puta tere - i roto i 15-20 meneti. Haunga te medicament "VFS" tikanga "Allaritmin" tūtohutia inu 3 wa ia ra 25 mg. Tangohia te rongoā kia i mua i te kai. Papa kuru e minaminatia. I roto i te take o te kore o te miramira kia nui haere ai inenga me te auau o te fariiraa. kawea whakahaere rō-uaua i roto i āta, i runga i te 5 meneti. Inenga whakaturia kupu rite ki te taimaha o te manawanui. Taunakitia e 0.3-0.4 mg / kg. I roto i ētahi wā e whakahaeretia ana toutou (tino nui) tarukino i runga i 6 haora. I roto i te uaua e whakahaeretia 0.4 mg / kg i wā o 6 haora. Kei te tuhia te reira e kore e tūtohu whakahaere rō-uaua ki te kawe i roto i te kāinga. Drug "Allaritmin" kua te taua here i runga i te whakamahi rite te rongoā "VFS". kawea maimoatanga i roto i roto i te hōhipera i raro i te tirotiro tamau o te rata, me te ECG aroturuki. He nui rawa i roto i te maimoatanga o te tūroro ki te tohu poraka atrioventricular tuatahi, kore ngakau, decompensated momo akoranga ma'i tenei.

mutunga

Tikanga "VFS", te whakamahi o nei me tino mana, rite tahi atu antiarrhythmics, no ki te kāwai o te raau taero puai. I roto i te ngaro o te pānga haumanu kore e nui ona ake ka tango i te inenga whakaritea o te mātanga. Ko e tika ana ki te meka i reira ko te mōrea o te haurangi me te pōauautanga muri tenei. I mua i te tautapa koe he tarukino, kia hoatu te tākuta te manawanui mōhio o te pānga taha taea me contraindications. I roto i te tahuri, parau te manawanui e pā ana ki te aroaro o te ātete kai, tae atu i roto i te hītori, i roto i tetahi pāpāho, me te te raau taero e te reira anō. I mua i te tango i tēnei rongoā kia tirotiro Tuhipuka.